phrykt

GSK plc (GSK): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of GSK were reported in the last 12 months. 7 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling GSK

From the latest filings

Overall: more buying than selling. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns GSK

1,034 funds and institutions reported GSK shares worth $18.2B at the end of Q2 2026, about 8% of the company. The largest holder is FMR LLC (Fidelity) with 1.5%.

Funds and institutions (13F) 8%Everyone else 92%

10 largest owners, by share of the company

FMR LLC (Fidelity)1.5%
Dodge & Cox1.1%
Fisher Asset Management, LLC0.8%
Primecap Management Co0.6%
Wellington Management Group LLP0.3%
JTC Employer Solutions Trustee Ltd0.2%
Morgan Stanley0.2%
Royal Bank of Canada0.2%
T. Rowe Price Associates0.2%
Acadian Asset Management LLC0.2%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
FMR LLC (Fidelity)64.96M1.51%$3.4B-4%
Dodge & Cox48.20M1.12%$2.5B-18%
Fisher Asset Management, LLC35.72M0.83%$1.9B+3%
Primecap Management Co25.18M0.58%$1.3B-0%
Wellington Management Group LLP11.40M0.26%$597M-3%
JTC Employer Solutions Trustee Ltd8.59M0.20%$450M-5%
Morgan Stanley7.66M0.18%$401M-31%
Royal Bank of Canada7.59M0.18%$398M+1%
T. Rowe Price Associates6.92M0.16%$363M-5%
Acadian Asset Management LLC6.66M0.15%$349M-44%
Goldman Sachs Group Inc6.37M0.15%$334M-34%
State Street Corp5.96M0.14%$315M-1%
Mondrian Investment Partners LTD4.91M0.11%$257M-2%
Bank of Montreal4.04M0.09%$212M-13%
BlackRock, Inc.3.62M0.08%$190M+2%
Grantham, Mayo, Van Otterloo & Co. LLC3.60M0.08%$189M+2%
Hotchkis & Wiley Capital Management LLC3.41M0.08%$179M-2%
Equity Investment Corp3.27M0.08%$171M+2%
UBS Group AG2.81M0.07%$147M+35%
Connor, Clark & Lunn Investment Management Ltd.2.77M0.06%$145M-2%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

No GSK insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

GSK short interest

16.15M GSK shares are sold short. Over the last 12 reports the number of shares short went up 19%.

As of Oct 30, 2026, 16.15M GSK shares were sold short, up 10.8% from the report before. At the average daily volume of 5.08M shares, buying them all back would take about 3.2 trading days (days to cover).

Shares short, % of all shares

0.32%May 15Jul 150.34%

Days to cover

3.2May 15Oct 306.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202616.15M–+11%5.08M3.2
Oct 15, 202614.58M–-1%6.82M2.1
Sep 30, 202614.80M–+1%3.58M4.1
Sep 15, 202614.65M–+8%2.66M5.5
Aug 31, 202613.55M–-8%2.83M4.8
Aug 14, 202614.78M–+2%3.32M4.5
Jul 31, 202614.52M–+6%5.68M2.6
Jul 15, 202613.76M0.32%+8%3.09M4.5
Jun 30, 202612.76M0.30%+52%3.85M3.3
Jun 15, 20268.40M0.19%-14%4.28M2.0
May 29, 20269.77M0.23%-28%3.08M3.2
May 15, 202613.57M0.31%+3%3.67M3.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded GSK

Since Nov 17, 2024, 4 members of Congress reported 5 purchases and 6 sales of GSK. The latest was a sale by Lisa C. McClain on Oct 31, 2025, reported Nov 21, 2025.

Purchases 5Sales 6

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Oct 31, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Sep 23, 2025Val T. Hoyle (D-OR)Sale$1K–$15KSpouseOct 10, 2025Report
Aug 4, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseSep 12, 2025Report
Jul 28, 2025Robert B. Aderholt (R-AL)Sale$1K–$15KSelfSep 10, 2025Report
Jun 24, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseAug 13, 2025Report
Jun 17, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Apr 21, 2025Bruce Westerman (R-AR)Sale$1K–$15KSelfMay 12, 2025Report
Mar 3, 2025Bruce Westerman (R-AR)Purchase$1K–$15KSelfApr 16, 2025Report
Nov 18, 2024Val T. Hoyle (D-OR)Purchase$1K–$15KSpouseSep 12, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Famous investors that hold GSK

7 of the 50 well-known investors we track reported holding GSK in their latest 13F filing. The largest position is Ken Fisher's, worth $1.7B.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Fisher · Fisher Asset ManagementQ3 202635.35M$1.7B0.5%-1%
Jeremy Grantham · GMOQ3 20263.92M$189M0.4%+9%
Ken Griffin · Citadel AdvisorsQ3 20261.17M$56.2M0.0%+669%
Ray Dalio · Bridgewater AssociatesQ3 2026548,661$26.4M0.1%+9%
Jim Simons · Renaissance TechnologiesQ3 2026466,340$22.5M0.0%New
Paul Tudor Jones · Tudor Investment CorpQ3 202678,013$3.8M0.0%New
Richard Pzena · Pzena Investment ManagementQ3 202628,964$1.4M0.0%+18%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about GSK plc (GSK) stock

Who owns the most GSK stock?

The largest reported owner of GSK plc (GSK) is FMR LLC (Fidelity), with 1.5% of the company. In total, 1,034 funds and institutions reported holding GSK at the end of Q2 2026, together about 8% of the shares. See the largest owners.

Are GSK insiders buying or selling?

No GSK insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in GSK?

As of Oct 30, 2026, 16.15M GSK shares were sold short, up 10.8% from the report before. At the average daily volume of 5.08M shares, buying them all back would take about 3.2 trading days (days to cover). See the history.

Have members of Congress traded GSK?

Yes. 4 members of Congress reported 5 purchases and 6 sales of GSK since Nov 17, 2024. The latest was reported on Nov 21, 2025. See the trades.

Which famous investors hold GSK?

7 of the 50 well-known investors we track reported GSK in their latest 13F filing, including Ken Fisher, Jeremy Grantham, Ken Griffin. The largest position is worth $1.7B. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.